Market Cap

Cybin, Inc. Market Capitalization:

C$577.9 Million

CAD as of Jan. 1, 2026

US$421.6 Million

business Cybin, Inc. Company Profile

Cybin, Inc. Main Stock Listing

NEO: CYBN

Market Capitalization History of Cybin, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Cybin, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 C$577.9 M 113.32%
Jan. 1, 2025 C$270.9 M 21.19%
Jan. 1, 2024 C$223.5 M 117.03%
Jan. 1, 2023 C$103.0 M -55.47%
Jan. 1, 2022 C$231.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Cybin, Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

Cybin, Inc. has the following listings and related stock indices.


Stock: NEO: CYBN

Stock: FSX: R7E1

Stock: NYSE: CYBN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.